1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Roche Holding AG
  6. Financials
    ROG   CH0012032048

ROCHE HOLDING AG

(ROG)
  Report
Delayed Swiss Exchange  -  11:30 2022-06-24 am EDT
318.80 CHF   +4.08%
06/23Galderma Announces Topline Results of OLYMPIA 2 Study Evaluating Nemolizumab in Prurigo Nodularis
AQ
06/23Novartis wins U.S. approval for targeted cancer drug combination
RE
06/21KENYA : Ministry signs agreement to enhance access to breast cancer treatment
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization1 267 779264 244306 810259 756--
Enterprise Value (EV)1 270 284266 126324 977271 017263 252253 844
P/E ratio 20,1x18,7x23,4x17,1x16,3x14,8x
Yield 2,87%2,94%2,45%3,04%3,14%3,28%
Capitalization / Revenue 4,36x4,53x4,89x4,08x4,03x3,80x
EV / Revenue 4,40x4,56x5,17x4,26x4,09x3,72x
EV / EBITDA 10,6x11,0x13,2x10,6x10,00x8,87x
Price to Book 8,28x7,27x13,2x6,96x5,92x5,03x
Nbr of stocks (in thousands) 856 061854 642800 952800 403--
Reference price (CHF) 314309379319319319
Announcement Date 01/30/202002/04/202102/03/2022---
1 CHF in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 61 46658 32362 80163 66764 42368 323
EBITDA1 25 41924 28124 69225 59726 33128 622
Operating profit (EBIT)1 22 47921 53621 89722 29923 21625 565
Operating Margin 36,6%36,9%34,9%35,0%36,0%37,4%
Pre-Tax Profit (EBT)1 16 61417 96517 39819 73620 85723 148
Net income1 13 49714 29513 93014 94715 76217 333
Net margin 22,0%24,5%22,2%23,5%24,5%25,4%
EPS2 15,616,516,218,719,621,6
Dividend per Share2 9,009,109,309,6910,010,5
Announcement Date 01/30/202002/04/202102/03/2022---
1 CHF in Million
2 CHF
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q3 2021 Q4 2021 S2 2022 Q1 2022 Q2 2022 S1
Net sales1 15 97116 11732 08816 44515 51931 643
EBITDA ------
Operating profit (EBIT) --10 245--12 296
Operating Margin --31,9%--38,9%
Pre-Tax Profit (EBT) --7 511--11 259
Net income --6 127--8 390
Net margin --19,1%--26,5%
EPS --7,15--10,4
Dividend per Share ------
Announcement Date 10/20/202102/03/202202/03/202204/25/2022--
1 CHF in Million
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt1 2 5051 88218 16711 2603 495-
Net Cash position1 -----5 912
Leverage (Debt / EBITDA) 0,10x0,08x0,74x0,44x0,13x-0,21x
Free Cash Flow1 16 76410 94315 69118 01017 24119 013
ROE (Net Profit / Equities) 57,7%48,0%56,0%54,1%44,7%39,1%
Shareholders' equity1 23 39229 78924 86727 65235 25544 310
ROA (Net Profit / Asset) 21,6%19,6%19,1%16,5%15,1%14,6%
Assets1 62 62172 96672 95190 548104 569118 330
Book Value Per Share2 37,942,528,845,853,963,3
Cash Flow per Share2 25,921,524,425,725,228,0
Capex1 3 5033 5283 6933 7953 8674 008
Capex / Sales 5,70%6,05%5,88%5,96%6,00%5,87%
Announcement Date 01/30/202002/04/202102/03/2022---
1 CHF in Million
2 CHF
Previous periodNext period
Estimates
Key data
Capitalization (CHF) 259 756 282 170
Capitalization (USD) 272 090 127 657
Net sales (CHF) 62 801 000 000
Net sales (USD) 65 782 940 702
Number of employees 100 920
Sales / Employee (CHF) 622 285
Sales / Employee (USD) 651 833
Free-Float 82,4%
Free-Float capitalization (CHF) 214 011 677 680
Free-Float capitalization (USD) 224 173 460 651
Avg. Exchange 20 sessions (CHF) 433 363 570
Avg. Exchange 20 sessions (USD) 453 940 701
Average Daily Capital Traded 0,17%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA